Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERG

被引：0

作者：

Mitsuyuki, Satoshi ^{[1
]}

Shimomura, Yoshimitsu ^{[1
,2
]}

Mizumaki, Hiroki ^{[3
]}

Yanada, Masamitsu ^{[4
]}

Mizuno, Shohei ^{[5
]}

Uchida, Naoyuki ^{[6
]}

Doki, Noriko ^{[7
]}

Ito, Ayumu ^{[8
]}

Tanaka, Masatsugu ^{[9
]}

Nishida, Tetsuya ^{[10
]}

Katayama, Yuta ^{[11
]}

Yoshihara, Satoshi ^{[12
]}

Eto, Tetsuya ^{[13
]}

Takada, Satoru ^{[14
]}

Ota, Shuichi ^{[15
]}

Toyosaki, Masako ^{[16
]}

Hasegawa, Yuta ^{[17
]}

Nakamae, Hirohisa ^{[18
]}

Kawamura, Koji ^{[19
]}

Onizuka, Makoto ^{[16
]}

Fukuda, Takahiro ^{[8
]}

Ohbiki, Marie ^{[20
,21
,22
]}

Atsuta, Yoshiko ^{[20
,21
]}

Konuma, Takaaki ^{[23
]}

机构：

[1] Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Japan

[2] Osaka Univ, Grad Sch Med, Dept Environm Med & Populat Sci, Suita, Osaka, Japan

[3] Kanazawa Univ, Dept Hematol, Kanazawa, Japan

[4] Nagoya City Univ, Dept Hematol & Oncol, East Med Ctr, Nagoya, Japan

[5] Aichi Med Univ, Dept Internal Med, Div Hematol, Sch Med, Nagakute, Japan

[6] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan

[7] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan

[8] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[9] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Japan

[10] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan

[11] Hiroshima Red Cross Hosp & Atom, Bomb Survivors Hosp, Dept Hematol, Hiroshima, Japan

[12] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Japan

[13] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan

[14] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Japan

[15] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Japan

[16] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan

[17] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan

[18] Osaka Metropolitan Univ Hosp, Dept Hematol, Osaka, Japan

[19] Tottori Univ, Dept Multidisciplinary Internal Med, Div Clin Lab Med, Yonago, Tottori, Japan

[20] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Japan

[21] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan

[22] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Japan

[23] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan

来源：

LEUKEMIA | 2025年 / 39卷 / 02期

关键词：

TRUMP DATA; CLASSIFICATION; SCRIPTS;

D O I：

10.1038/s41375-024-02495-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：495 / 498

页数：4

共 50 条

[41] Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
Pullarkat S.T.
Pullarkat V.
Kroft S.H.
Wilson C.S.
Ahsanuddin A.N.
Mann K.P.
Thein M.
Grody W.W.
Brynes R.K.
Journal of Hematopathology, 2009, 2 (1) : 27 - 33
[42] Translocation t(8;21)(q22;q22) and its variants in acute myeloid leukemia
Jovanovi, J.
Evi, Vesna Or
Deni-Fekete, M.
Bii, S.
Goti, M.
Bokovi, D.
CHROMOSOME RESEARCH, 2005, 13 : 190 - 190
[43] Systemic mastocytosis with an associated t(8;21)(q22;q22) acute myeloid leukemia
Wimmer, Jordan
Hurstel, Remy
BLOOD, 2021, 137 (18) : 2564 - 2564
[44] Overexpression of HHEX in Acute Myeloid Leukemia with t(8;21)(q22;q22) Translocation
Zhang, Shuangfeng
Ma, Liang
Chen, Yafeng
Xu, Huan
Chen, Suning
Wu, Wenzhong
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2017, 47 (06): : 687 - 697
[45] Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)
Bacher, Ulrike
Schnittger, Susanne
Kern, Wolfgang
Trenn, Guido
Weisser, Martin
Haferlach, Torsten
Schoch, Claudia
CANCER GENETICS AND CYTOGENETICS, 2006, 168 (02) : 172 - 174
[46] Prognosis and treatment outcome in patients with acute myeloid Leukemia with t(8;21)(q22;q22)
Chih-Cheng Chen
Jyh-Pyng Gau
Yuan-Bin Yu
Chang-Hsien Lu
Kuan-Der Lee
Jie-Yu You
Advances in Therapy, 2007, 24 : 907 - 920
[47] Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22)
Chen, Chih-Cheng
Gau, Jyh-Pyng
Yu, Yuan-Bin
Lu, Chang-Hsien
Lee, Kuan-Der
You, Jie-Yu
ADVANCES IN THERAPY, 2007, 24 (04) : 907 - 920
[48] Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)
Lixia Zhang
Qinghua Li
Wei Li
Bingcheng Liu
Ying Wang
Dong Lin
Chunlin Zhou
Chengwen Li
Jianxiang Wang
Yingchang Mi
International Journal of Hematology, 2013, 97 : 786 - 792
[49] Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)
Zhang, Lixia
Li, Qinghua
Li, Wei
Liu, Bingcheng
Wang, Ying
Lin, Dong
Zhou, Chunlin
Li, Chengwen
Wang, Jianxiang
Mi, Yingchang
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (06) : 786 - 792
[50] Acute myeloid leukemia t(8;21)(q22;q22) ON Abbott's Alinity hq
Silva, S.
Van Dun, L.
Sun, L.
Ismail, M.
Rongey, C.
CLINICA CHIMICA ACTA, 2024, 558

← 1 2 3 4 5 →